À propos de GlycoNet
Qui nous sommes
Comité des Finances et de Vérification
Comité des Nominations
Research Management Committee
Conseil Consultatif Scientifique
Commercialization & Legacy Committee
Equity, Diversity and Inclusion Committee
Comité de Formation
Équité, diversité et inclusion
Le Comité de Formation évalue et recommande des initiatives, y compris, mais sans s’y limiter, des bourses de voyages et de recherche, pour soutenir la mission de formation de GlycoNet. Le association des stagiaires de GlycoNet est composé de personnel hautement qualifié (PHQ) sélectionné par le Comité de Formation et sert de liaison entre le Réseau et la communauté de PHQ.
Robert Britton is a Michael Smith Foundation for Health Research Career Scholar and his research program focuses on the concise synthesis of structurally and stereochemically complex natural products and the discovery of new synthetic methods to support drug discovery and development.
Chantelle Capicciotti is a Queen’s National Scholar in Precision Molecular Medicine, jointly appointed in the Departments of Chemistry and Biomedical and Molecular Sciences at Queen’s University. Her research focuses on understanding how glycans/glycoproteins interact with binding-proteins at a cellular level to elicit biological function, and on developing glycan-based approaches for biomarker identification, disease diagnosis, imaging techniques, and cell-based therapies.
John joined Bloom Burton & Co. in January 2012. At Bloom Burton, John’s responsibilities include M&A advisory, licensing advisory and monetization planning, as well as conducting technical and commercial due diligence on companies across all healthcare sectors. John’s area of expertise spans early-stage technologies to profitable healthcare service companies, with a particular focus on preclinical-stage biotech.
Ifthiha is a postdoctoral fellow who joined the Mahal Lab in October 2021. She completed her
Ph.D. in Biology at Concordia University, Montreal in the summer of 2021. During her Ph.D.,
she worked in the lab of Dr. David Kwan, where she focused on researching and harnessing the
substrate flexibility of enzymes involved in natural product glycosylation towards better
Warren is a Professor from the Department of Biological Sciences at the University of Alberta. The Wakarchuk lab investigates the structure and function of the enzymes which make and degrade various glycoconjugates. This work has been enabling the chemo-enzymatic synthesis of bioactive glycoconjugates both in the laboratory and for industrial projects. The Wakarchuk lab has expertise with both mammalian and bacterial carbohydrate active enzymes for glycan remodelling applications.
Dr. Williams received her PhD from the University of Guelph in 2013. She completed her postdoctoral fellowship in surgery at Western University and is now an Assistant Professor at UBC Pharmaceutical Sciences.
Elizabeth is the CEO of GlycoNet. She was involved in the GlycoNet initiative since the Letter of Intent stage and served as the Associate Director, Business for the Alberta Glycomics Centre from 2007–2015. Prior to her position with the Centre, she worked as a manager of large-scale and multi-institutional projects with Genome Prairie. In addition to her PhD in biochemistry, Elizabeth has an MBA in biotechnology management.
Réseau Canadien de la Glycomique
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
© Réseau Canadien de la Glycomique (GlycoNet). Tous droits réservés.